This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Aug;3(8):579-81.

doi: 10.1016/S2213-8587(15)00133-3. Epub 2015 Jun 17.

Metformin in chronic kidney disease: more harm than help?

Kamyar Kalantar-Zadeh¹, Connie M Rhee²

Affiliations

Affiliations

¹ Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA 92868, USA; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA. Electronic address: kkz@uci.edu.
² Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA 92868, USA.

PMID: 26094106
DOI: 10.1016/S2213-8587(15)00133-3

Free article

Comment

Metformin in chronic kidney disease: more harm than help?

Kamyar Kalantar-Zadeh et al. Lancet Diabetes Endocrinol. 2015 Aug.

Free article

. 2015 Aug;3(8):579-81.

doi: 10.1016/S2213-8587(15)00133-3. Epub 2015 Jun 17.

Authors

Kamyar Kalantar-Zadeh¹, Connie M Rhee²

Affiliations

¹ Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA 92868, USA; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA. Electronic address: kkz@uci.edu.
² Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA 92868, USA.

PMID: 26094106
DOI: 10.1016/S2213-8587(15)00133-3

Erratum in

Lancet Diabetes Endocrinol. 2015 Aug;3(8):e6

No abstract available

PubMed Disclaimer

Comment on

Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
Hung SC, Chang YK, Liu JS, Kuo KL, Chen YH, Hsu CC, Tarng DC. Hung SC, et al. Lancet Diabetes Endocrinol. 2015 Aug;3(8):605-14. doi: 10.1016/S2213-8587(15)00123-0. Epub 2015 Jun 17. Lancet Diabetes Endocrinol. 2015. PMID: 26094107

Similar articles

Mortality and metformin use in patients with advanced chronic kidney disease.
Lalau JD, Kajbaf F, Arnouts P, de Broe M. Lalau JD, et al. Lancet Diabetes Endocrinol. 2015 Sep;3(9):680-1. doi: 10.1016/S2213-8587(15)00285-5. Lancet Diabetes Endocrinol. 2015. PMID: 26298570 No abstract available.
Chronic kidney disease: Metformin increases risk of mortality in patients with advanced chronic kidney disease.
Edwards JK. Edwards JK. Nat Rev Nephrol. 2015 Aug;11(8):443. doi: 10.1038/nrneph.2015.110. Epub 2015 Jul 7. Nat Rev Nephrol. 2015. PMID: 26149836 No abstract available.
Mortality and metformin use in patients with advanced chronic kidney disease--Authors' reply.
Hung SC, Chang YK, Liu JS, Hsu CC, Tarng DC. Hung SC, et al. Lancet Diabetes Endocrinol. 2015 Sep;3(9):681. doi: 10.1016/S2213-8587(15)00287-9. Lancet Diabetes Endocrinol. 2015. PMID: 26298571 No abstract available.
[Proposal for the modification of metformin use in patients with chronic kidney disease].
Balogh Z, Mátyus J. Balogh Z, et al. Orv Hetil. 2012 Sep 30;153(39):1527-35. doi: 10.1556/OH.2012.29448. Orv Hetil. 2012. PMID: 23000419 Review. Hungarian.
Toxicity of Metformin and Hypoglycemic Therapies.
Akhter MS, Uppal P. Akhter MS, et al. Adv Chronic Kidney Dis. 2020 Jan;27(1):18-30. doi: 10.1053/j.ackd.2019.08.004. Adv Chronic Kidney Dis. 2020. PMID: 32146997 Review.

See all similar articles

Cited by

Anticonstriction Effect of MCA in Rats by Danggui Buxue Decoction.
Guo Y, Zhang Y, Hou Y, Guo P, Wang X, Zhang S, Yang P. Guo Y, et al. Front Pharmacol. 2021 Nov 8;12:749915. doi: 10.3389/fphar.2021.749915. eCollection 2021. Front Pharmacol. 2021. PMID: 34867357 Free PMC article.
Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis.
Rhee CM, Kalantar-Zadeh K. Rhee CM, et al. Nat Rev Nephrol. 2017 Dec 13;14(1):70. doi: 10.1038/nrneph.2017.174. Nat Rev Nephrol. 2017. PMID: 29234161 No abstract available.
Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.
Rhee CM, Kovesdy CP, Kalantar-Zadeh K. Rhee CM, et al. Nephron. 2017;135(2):147-153. doi: 10.1159/000450862. Epub 2016 Oct 20. Nephron. 2017. PMID: 27760420 Free PMC article.
Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Kalantar-Zadeh K, Kovesdy CP. Kalantar-Zadeh K, et al. Diabetes Care. 2016 Jul;39(7):1281-6. doi: 10.2337/dc15-2327. Diabetes Care. 2016. PMID: 27330129 Free PMC article.
Restricting Metformin in CKD: Continued Caution Warranted.
Rhee CM, Kalantar-Zadeh K. Rhee CM, et al. Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039. Am J Kidney Dis. 2015. PMID: 26593314 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information